Adverse events64

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 64

Type	Event	Organ system	Group	Affected	At risk
other	Injection site pain	General disorders	Placebo	4	63
other	Injection site pain	General disorders	Brodalumab 70 mg	2	63
other	Injection site pain	General disorders	Brodalumab 140 mg	2	63
other	Injection site pain	General disorders	Brodalumab 210 mg	2	63
other	Nasopharyngitis	Infections and infestations	Placebo	2	63
other	Nasopharyngitis	Infections and infestations	Brodalumab 70 mg	3	63
other	Nasopharyngitis	Infections and infestations	Brodalumab 140 mg	4	63
other	Nasopharyngitis	Infections and infestations	Brodalumab 210 mg	4	63
other	Upper respiratory tract infection	Infections and infestations	Placebo	1	63
other	Upper respiratory tract infection	Infections and infestations	Brodalumab 70 mg	4	63
other	Upper respiratory tract infection	Infections and infestations	Brodalumab 140 mg	5	63
other	Upper respiratory tract infection	Infections and infestations	Brodalumab 210 mg	3	63
other	Urinary tract infection	Infections and infestations	Placebo	1	63
other	Urinary tract infection	Infections and infestations	Brodalumab 70 mg	2	63
other	Urinary tract infection	Infections and infestations	Brodalumab 140 mg	5	63
other	Urinary tract infection	Infections and infestations	Brodalumab 210 mg	4	63
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	Placebo	5	63
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	Brodalumab 70 mg	4	63
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	Brodalumab 140 mg	7	63
other	Rheumatoid arthritis	Musculoskeletal and connective tissue disorders	Brodalumab 210 mg	0	63

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00950989/events

API reference For AI assistants

Adverse events64

Sources 3

Read this list from software.